Rituvanthikaa Seethapathy

Years Active: 2021-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Rituvanthikaa Seethapathy, Qiyu Wang, Sophia Zhao, Ian A Strohbehn, Joshua D Long, James E Dinulos, Destiny Harden, Vinay B Kadiyala, Daiana Moreno, Meghan E Sise
Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function. PloS one 18 (2) (2023)
Rituvanthikaa Seethapathy, Qiyu Wang, Sophia Zhao, Ian A Strohbehn, Joshua D Long, James E Dinulos, Destiny Harden, Vinay B Kadiyala, Daiana Moreno, Meghan E Sise
Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function. PloS one 18 (2) (2023)
Rituvanthikaa Seethapathy, Qiyu Wang, Sophia Zhao, Ian A Strohbehn, Joshua D Long, James E Dinulos, Destiny Harden, Vinay B Kadiyala, Daiana Moreno, Meghan E Sise
Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function. PloS one 18 (2) (2023)
Ian A Strohbehn, Rituvanthikaa Seethapathy, Meghan Lee, Meghan E Sise
Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease. Kidney360 2 (8) (2021)
Rituvanthikaa Seethapathy, Sophia Zhao, Joshua D Long, Ian A Strohbehn, Meghan E Sise
A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease. Kidney360 3 (2) (2021)

Rituvanthikaa Seethapathy.css-eqlu8i{font-size:small;padding-left:4px;}